Cytena launches new microbioreactor
Cellink company Cytena Bioprocess Solutions has unveiled its new S.Nest microbioreactor. Read More
AI drug development startups raised $2.1B in 1st half of 2021
The market for artificial intelligence (AI) in drug development and discovery has been red-hot in recent years. The potential impact that AI can offer to human health and pharmaceutical development has grown in concert with the enabling technologies in computer processing and digitization, as well as new breakthroughs in machine-learning research. Ulrik Kristensen, PhD, of Emersion Insights offers a perspective. Read More
Thermo Fisher announces new suite of assays
Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T cells and B cells. Read More
5 ways to improve the biomanufacturing workforce in regenerative medicine
A national survey of regenerative medicine biomanufacturing has revealed gaps in the training of skilled technical workers. The group behind the survey has proposed five steps to improve workforce quality and recently published its recommendations in Stem Cells Translational Medicine. Read More
LabGenius announces research collaboration with Ablynx
LabGenius has announced a research collaboration with Ablynx, a Sanofi company, for therapeutic proteins. Read More
GSK to establish new life science campus in U.K.
GlaxoSmithKline (GSK) has announced plans to develop a more than 1 million-sq-ft life science campus research and development campus in Stevenage, England. Read More
Grit Bio secures funding for development of TIL therapies
Grit Bio has secured a round of financing that it plans to use to develop tumor-infiltrating lymphocyte (TIL) therapies. The funding amount was not disclosed. Read More
Iodine-activated nanoparticles trigger DNA damage in cancer cells
Newly designed nanoparticles containing iodine have been shown to kill cancer cells by causing DNA damage when activated by radiation. The in vitro findings were published in Scientific Reports on July 14. Read More
Thermo Fisher opens cGMP plasmid DNA manufacturing facility in Calif.
Thermo Fisher Scientific announced it has officially opened its new current good manufacturing practice (cGMP) plasmid DNA manufacturing facility in Carlsbad, CA, a step the company hopes will help it meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines. Read More
Wugen nabs $172M to advance memory NK cell platform
Wugen announced it has raised $172 million to support further development of its NK cell platform and to continue ongoing trials for patients with severe acute myelogenous leukemia. Read More
Conferences
CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
Online
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter